Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
NCT01458171
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Immune Deficiency Disorder
Interventions
BIOLOGICAL:
Immune globulin subcutaneous (Human)
Sponsor
CSL Behring